Início/Ações/CNSP

CNSP

USD

CNS Pharmaceuticals Inc. Common Stock

$6.600-0.420 (-5.983%)

Preço em tempo real

Healthcare

Biotecnologia

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$7.020

Máximo

$7.020

Mínimo

$6.500

Volume

0.01M

Fundamentos da empresa

Capitalização de mercado

3.8M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.05M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $4.93Atual $6.600Máximo $114

Notícias relacionadas

12/09/2025 · 14:08

Analyst Upgrades

Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target

Maxim Group analyst Jason McCarthy upgrades CNS Pharma from Hold to Buy and announces $20 price target.

Ver mais

Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target

3/09/2025 · 13:15

AccessWire

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

HOUSTON, TX / ACCESS Newswire / September 3, 2025 / CNS Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the development of novel treatments

Ver mais

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

27/08/2025 · 12:00

GlobeNewswire

IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.

AUSTIN, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of

Ver mais